BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 95.00
-3.00 (-3.06%)
At close: Oct 23, 2026
BioInfra Life Science Market Cap
BioInfra Life Science has a market cap or net worth of 2.06 billion as of October 23, 2026. It is the 48,551st most valuable company in the world and the 2,726th biggest in South Korea. Its market cap has decreased by 54.55% in one year.
Market Cap
2.06B
Enterprise Value
n/a
Revenue
1.78B
Global Rank
Country Rank
#2,726 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 22, 2020, BioInfra Life Science's market cap has decreased from 57.13B to 2.06B, a decrease of -96.40%. That is a compound annual growth rate of -41.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 2.06B | -65.45% |
| Dec 30, 2025 | 5.96B | -33.89% |
| Dec 30, 2024 | 9.01B | 75.26% |
| Dec 28, 2023 | 5.14B | -65.89% |
| Dec 29, 2022 | 15.08B | -60.07% |
| Dec 30, 2021 | 37.76B | -10.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 73.70B |
| Corentec | 64.76B |
| DENTIS CO.,Ltd | 38.65B |
| Finemedix | 32.26B |
| Genolution | 29.27B |
| Sanigen Co. | 28.08B |
| TASCOM | 21.71B |
| Alpha AI | 10.45B |